Bio-Rad Laboratories, Inc. (BIO) EPS Diluted: 27.87
Is Bio-Rad Laboratories, Inc.’s EPS diluted high or low?
Bio-Rad Laboratories, Inc.'s EPS diluted of 27.87 is 95% above its 5-year average of 14.32, around the middle of its 5-year range (-121.79–140.83).
248.68% above its 12-month average of -18.74.
BIO EPS Diluted Chart
BIO Average EPS Diluted Chart
BIO Current vs Average EPS Diluted Chart
BIO EPS Diluted Metrics
EPS DILUTED
27.87
EPS DILUTED AVG TTM
-18.74
EPS DILUTED AVG 3Y
-45.28
EPS DILUTED AVG 5Y
14.32
EPS DILUTED AVG 10Y
14.98
EPS DILUTED AVG 15Y
11.83
EPS DILUTED AVG 20Y
9.90
CURRENT VS TTM AVG
+248.68%
CURRENT VS 3Y AVG
+161.56%
CURRENT VS 5Y AVG
+94.60%
CURRENT VS 10Y AVG
+86.03%
CURRENT VS 15Y AVG
+135.69%
CURRENT VS 20Y AVG
+181.46%
Bio-Rad Laboratories, Inc. EPS Diluted Formula & Definition
EPS Diluted includes the effect of convertible securities, options, and other potential shares. Compare it with basic EPS to see the impact of potential dilution.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Bio-Rad Laboratories, Inc. EPS Diluted FAQ
- What is the EPS diluted for Bio-Rad Laboratories, Inc. (BIO)?
- The EPS diluted for BIO stock is 27.87.
- Is Bio-Rad Laboratories, Inc.'s EPS diluted high or low?
- Bio-Rad Laboratories, Inc.'s EPS diluted of 27.87 is 95% above its 5-year average of 14.32, around the middle of its 5-year range (-121.79–140.83).
- What is the TTM average EPS diluted for Bio-Rad Laboratories, Inc. (BIO)?
- The TTM average EPS diluted for BIO stock is -18.74.
- What is the 3Y average EPS diluted for Bio-Rad Laboratories, Inc. (BIO)?
- The 3Y average EPS diluted for BIO stock is -45.28.
- What is the 5Y average EPS diluted for Bio-Rad Laboratories, Inc. (BIO)?
- The 5Y average EPS diluted for BIO stock is 14.32.
- What is the 10Y average EPS diluted for Bio-Rad Laboratories, Inc. (BIO)?
- The 10Y average EPS diluted for BIO stock is 14.98.
- What is the 15Y average EPS diluted for Bio-Rad Laboratories, Inc. (BIO)?
- The 15Y average EPS diluted for BIO stock is 11.83.
- What is the 20Y average EPS diluted for Bio-Rad Laboratories, Inc. (BIO)?
- The 20Y average EPS diluted for BIO stock is 9.90.
Bio-Rad Laboratories, Inc. EPS Diluted History
| DATE | EPS DILUTED |
|---|---|
| 2025-12-31 | 27.87 |
| 2024-12-31 | -65.36 |
| 2023-12-31 | -21.82 |
| 2022-12-31 | -121.79 |
| 2021-12-31 | 140.83 |
| 2020-12-31 | 126.20 |
| 2019-12-31 | 58.27 |
| 2018-12-31 | 11.94 |
| 2017-12-31 | 4.07 |
| 2016-12-31 | 0.88 |
| 2015-12-31 | 3.71 |
| 2014-12-31 | 3.05 |
| 2013-12-31 | 2.69 |
| 2012-12-31 | 5.78 |
| 2011-12-31 | 6.29 |
| 2010-12-31 | 6.59 |
| 2009-12-31 | 5.20 |
| 2008-12-31 | 3.24 |
| 2007-12-31 | 3.41 |
| 2006-12-31 | 3.83 |
| 2005-12-31 | 3.06 |
| 2004-12-31 | 2.58 |
| 2003-12-31 | 2.90 |
| 2002-12-31 | 2.61 |
| 2001-12-31 | 1.74 |
| 2000-12-31 | 1.27 |
| 1999-12-31 | 0.48 |
| 1998-12-31 | 0.99 |
| 1997-12-31 | 0.66 |
| 1996-12-31 | 1.05 |
Related Metrics
About Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Norman D. Schwartz